MDWD Mediwound Ltd.
MediWound Ltd is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and others.
$1.82
As of 05/20/2022 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: Israel
Country of incorporation: Israel
IPO date: 03/20/2014
Outstanding shares: 33,078,511
Average volume: 110,190
Market cap: $59,541,320
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%